Daiichi Sankyo, GENESIS Pharma Agree on VANFLYTA® in CEE
Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13...
Tag : GENESIS Pharma
GENESIS Pharma Partners with Otsuka for Donidalorsen in CEE
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative...